A share price of Exelixis Inc [EXEL] is currently trading at $21.53, up 3.96%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EXEL shares have gain 4.57% over the last week, with a monthly amount drifted -2.62%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 6, February 2024, Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update. In a post published today on Yahoo Finance, – Total Revenues of $480 million for the Fourth Quarter of 2023, $1,830 million for the Fiscal Year 2023 -.
From an analyst’s perspective:
Exelixis Inc [NASDAQ: EXEL] stock has seen the most recent analyst activity on December 19, 2023, when BTIG Research initiated its Buy rating and assigned the stock a price target of $27. Previously, Citigroup started tracking the stock with Buy rating on December 15, 2023, and set its price target to $31. On September 26, 2023, H.C. Wainwright initiated with a Buy rating and assigned a price target of $28 on the stock. Oppenheimer reiterated its Outperform rating and increased its price target to $29 on August 22, 2023. SVB Securities initiated its recommendation with a Market Perform and recommended $18 as its price target on August 08, 2023.
Exelixis Inc experienced fluctuations in its stock price throughout the past year between $16.15 and $24.34. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Exelixis Inc [NASDAQ: EXEL] shares were valued at $21.53 at the most recent close of the market. An investor can expect a potential return of 20.76% based on the average EXEL price forecast.
Analyzing the EXEL fundamentals
Trailing Twelve Months sales for Exelixis Inc [NASDAQ:EXEL] were 1.83B which represents 13.15% growth. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.19 points at the first support level, and at 20.84 for the second support level. However, for the 1st resistance point, the stock is sitting at 21.83, and for the 2nd resistance point, it is at 22.12.
Exelixis Inc [EXEL] reported earnings per share of $0.27 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.21/share, meaning a difference of $0.06 and a surprise factor of 28.60%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0 per share as compared to estimates of $0.09 per share, a difference of -$0.09 representing a surprise of -100.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Exelixis Inc [NASDAQ:EXEL] is 3.34. As well, the Quick Ratio is 3.30, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 3.57, the price to book ratio is 2.88 and price to earnings (TTM) ratio is 33.27.
Transactions by insiders
Recent insider trading involved JOHNSON DAVID EDWARD, Director, that happened on Feb 21 when 0.19 million shares were purchased. EVP, Commercial, Haley Patrick J. completed a deal on Dec 14 to sell 50000.0 shares. Meanwhile, EVP, General Counsel & Sec Hessekiel Jeffrey sold 25000.0 shares on Dec 13.
